Jens Bjørheim
Technik-/Wissenschafts-/F&E-Leiter bei ULTIMOVACS ASA
Vermögen: - $ am 30.04.2024
Aktive Positionen von Jens Bjørheim
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ULTIMOVACS ASA | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Jens Bjørheim
Ehemalige bekannte Positionen von Jens Bjørheim
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 01.01.2013 | 01.01.2016 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | 01.01.2008 |
Ausbildung von Jens Bjørheim
University of Oslo | Doctorate Degree |
Statistik
International
Norwegen | 4 |
Dänemark | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ULTIMOVACS ASA | Health Technology |
Private Unternehmen | 2 |
---|---|
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
- Börse
- Insiders
- Jens Bjørheim
- Erfahrung